HJIM
Henry James International Management’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.05M | Hold |
57,963
| – | – | 1.33% | 27 |
|
|
2025
Q1 | $4.26M | Hold |
57,963
| – | – | 1.46% | 23 |
|
|
2024
Q4 | $3.8M | Sell |
57,963
-8,109
| -12% | -$531K | 1.37% | 26 |
|
|
2024
Q3 | $5.15M | Sell |
66,072
-1,521
| -2% | -$119K | 1.79% | 18 |
|
|
2024
Q2 | $5.27M | Buy |
67,593
+17,204
| +34% | +$1.34M | 1.87% | 17 |
|
|
2024
Q1 | $3.41M | Buy |
50,389
+19,557
| +63% | +$1.32M | 1.05% | 32 |
|
|
2023
Q4 | $2.08M | Buy |
30,832
+9,506
| +45% | +$640K | 0.78% | 42 |
|
|
2023
Q3 | $1.44M | Buy |
21,326
+12,350
| +138% | +$836K | 0.63% | 47 |
|
|
2023
Q2 | $642K | Hold |
8,976
| – | – | 0.28% | 67 |
|
|
2023
Q1 | $623K | Hold |
8,976
| – | – | 0.26% | 74 |
|
|
2022
Q4 | $609K | Buy |
8,976
+1,407
| +19% | +$95.4K | 0.29% | 72 |
|
|
2022
Q3 | $415K | Hold |
7,569
| – | – | 0.23% | 82 |
|
|
2022
Q2 | $500K | Hold |
7,569
| – | – | 0.25% | 79 |
|
|
2022
Q1 | $502K | Hold |
7,569
| – | – | 0.2% | 83 |
|
|
2021
Q4 | $441K | Sell |
7,569
-18
| -0.2% | -$1.05K | 0.14% | 113 |
|
|
2021
Q3 | $456K | Hold |
7,587
| – | – | 0.14% | 110 |
|
|
2021
Q2 | $454K | Sell |
7,587
-14
| -0.2% | -$838 | 0.13% | 119 |
|
|
2021
Q1 | $378K | Hold |
7,601
| – | – | 0.11% | 136 |
|
|
2020
Q4 | $380K | Sell |
7,601
-1,900
| -20% | -$95K | 0.13% | 102 |
|
|
2020
Q3 | $521K | Sell |
9,501
-3,105
| -25% | -$170K | 0.21% | 80 |
|
|
2020
Q2 | $667K | Sell |
12,606
-219
| -2% | -$11.6K | 0.28% | 74 |
|
|
2020
Q1 | $573K | Hold |
12,825
| – | – | 0.29% | 76 |
|
|
2019
Q4 | $639K | Hold |
12,825
| – | – | 0.25% | 93 |
|
|
2019
Q3 | $572K | Buy |
12,825
+883
| +7% | +$39.4K | 0.24% | 93 |
|
|
2019
Q2 | $493K | Sell |
11,942
-254
| -2% | -$10.5K | 0.21% | 101 |
|
|
2019
Q1 | $493K | Hold |
12,196
| – | – | 0.22% | 97 |
|
|
2018
Q4 | $463K | Buy |
12,196
+701
| +6% | +$26.6K | 0.3% | 93 |
|
|
2018
Q3 | $455K | Buy |
+11,495
| New | +$455K | 0.17% | 182 |
|